Practicability and quality of outpatient management of acute deep venous thrombosis  by Blättler, Werner et al.
For many years, we used a standardized strategy
designed for outpatient management.4,5 The concept
is that all patients coming to our vascular center are
worked up and treated as outpatients. Hospital
admission is considered only for patients who are
candidates for thrombolysis or thrombectomy.
We present the results of an internal audit of the
management of 156 consecutive cases. The retro-
spective survey covered the process of diagnosis and
the first 4 weeks of treatment. We chose this time
period because we thought that all adverse events
eventually preventable with hospital admission
would have occurred by then.
PATIENTS AND METHODS
Care was provided for 152 patients with 156
episodes of acute DVT. The demographic and clini-
Outpatient treatment of acute deep venous throm-
bosis (DVT) is effective, safe and practicable.1-3
However, concerns persist with regard to the accuracy
of diagnosis, the selection of patients, and the quality
of treatment if care is provided under the conditions of
clinics and private practices.
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Practicability and quality of outpatient
management of acute deep venous
thrombosis
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Zurich, Switzerland
Purpose: The purpose of this study was to review the practicability and quality of a
standardized management approach of deep venous thrombosis (DVT) provided by
private practices.
Methods: There were 152 consecutive patients and 156 episodes. We determined the
patients’ diagnoses with estimation of clinical probability, D-dimers, duplex ultrasound
scan, and venography. Patients were treated on an outpatient basis on principle, with dal-
teparin, phenprocoumon, different modalities of external leg compression, and deliber-
ate ambulation. We followed up at 4 weeks.
Results: Proximal DVT was diagnosed in 101 episodes (65%). Results of the D-dimer test
were false-negative in 6%, and venography was indicated in 15%. Calf vein thrombosis
was found in 55 patients. Results of the D-dimer test were false-negative in 30%, and
venography was required in 37%. Eleven patients were hospitalized (9 for thrombectomy
or thrombolysis), and 145 episodes (93%) were treated according to our standardized
approach (provided by the referring physicians alone in 43%). For 5 days, dalteparin was
injected by the patients themselves or their relatives, in 78% of the cases. The interna-
tional normalized ratio values were more than 2 in 88% of the cases, with no difference
between providers. In all but two cases, external leg compression was applied immedi-
ately: a modified Unna’s boot in 28% and compressing stockings in 72% (Sigvaris 503 in
91%; calf length in 100% of distal DVT, and 83% of proximal DVT). During follow-up,
there was no clinical evidence of recurrence or progression, 1 possible pulmonary
embolism, 1 injection site hematoma, and 1 hospitalization unrelated to the DVT. 
Conclusion: Diagnosis of proximal DVT is straightforward, but calf DVT often requires veno-
graphic confirmation because of discrepancies among clinical probability, D-dimer estimation,
and ultrasound scan. Outpatient treatment can be offered to patients who can comply with
the regimen. The quality of anticoagulation is in accordance with published data, and com-
pliance with external leg compression is almost perfect. (J Vasc Surg 2000;32:855-60.)
cal characteristics of the study population are listed
in Table I. 
Sequential diagnostic steps included (1) the
assessment of clinical probability of DVT and a
search for alternative explanations for the symptoms
and findings, both by the referring physician and at
the vascular center; (2) the measurement of the
blood concentration of D-dimers (SimpliRED;
Agen Biomedical, Brisbane, Australia); and (3) com-
pression or color-coded duplex sonography (Logic
500; General Electric, Fairfield, Conn). The veins of
the symptomatic extremity were scanned proximally
to distally until a thrombus was identified. The pos-
terior tibial, peroneal, gastrocnemial, and soleal
veins were examined only if no proximal thrombus
was found. Ascending contrast venography was per-
formed in the case of an inconclusive ultrasound
scan (eg, in a traumatized leg) or of a positive scan
finding in the context of a low clinical probability or
a negative D-dimer assay. 
We planned to generally provide treatment on an
outpatient basis. Exceptions were for candidates
undergoing restitutive procedures. A combination of
thrombolysis and thrombectomy6 was offered to
young patients with an extensive first DVT, a short
duration of symptoms, and no contraindication.
Hospitalization was also contemplated for patients
evidently unfit for home treatment; namely, those
who were unwilling or believed unable to comply
with the regimen and those who had nobody to assist
them. Outpatients were kept mobile and scheduled
for visits at the vascular center or the practitioners’
offices. The therapeutic regimen intended to be used
in each case included (1) the low molecular weight
heparin dalteparin (Fragmin; Pharmacia & Upjohn,
Dübendorf, Switzerland; 200 IU/kg bw, adminis-
tered once daily, for 5 days or until the international
normalized ratio [INR] was > 2.0), (2) the vitamin K
antagonist phenprocoumon (Marcoumar; Roche
Pharma, Reinach, Switzerland; started on day 1, with
daily doses of 9, 6, 6, and 3 mg, respectively, and a
target INR of 2.4 with a range of 2-3), (3) external
leg compression with Sigvaris 503 or 504 stockings
(Ganzoni, St Gallen, Switzerland) or fixed minimally
elastic bandages (Porelast; Lohmann & Rauscher,
Neuwied, Germany) described as a modification of
Unna’s boot,7,8 and (4) deliberate ambulation. The
choice of external leg compression was made accord-
ing to our experience of more than two decades,
which showed that a class II calf-size stocking suits
most patients. Class III stockings were chosen when
the skin was slightly infiltrated. The size was mea-
sured on the healthy leg. Bandages were applied if
severe edema (difference of circumference ≥ 5 cm) or
dermatosclerosis was present, if we had doubts
whether the patient would continue or resume walk-
ing, and if the patient could not handle the hosiery.
The stockings were usually removed at night while
the bandages remained on the leg.
Follow-up examinations of outpatients were
scheduled at 4 weeks. Sixty-five patients were exam-
ined at the center; 80 were examined by the refer-
ring physician. A form was completed for all patients
with questions on signs and symptoms of clinical
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Table I. Demographic and clinical characteristics of 152 patients and 156 episodes 
Age, y (median range) 58 (18-96)
Male sex (%) 48
Left DVT (%) 56
Recurrent DVT (%) 29
Risk factors and causes of DVT (%)
No triggering event identified 58
Cancer 8
Disorder of the leg in addition to DVT
Trauma/cellulitis/recent surgery/paresis 18
Superficial phlebitis 16
Interval of days since first symptoms appeared, d (mean range)* 14 (1-180)
Interval since definite symptoms appeared, d (mean, range)† 4.8 (1-30)
Localization of DVT, n (%)
Calf veins 55 (35)
Proximal veins 101 (65)
Popliteal 39 (25)
Femoral 42 (27)
Pelvic 20 (13)
Chest pain and/or dyspnea suspicious of PE (%) 13
*Information from 112 episodes.
†Information from 120 episodes.
DVT, Deep venous thrombosis; PE, pulmonary embolism.
progression or recurrence, the practicability and
quality of the anticoagulant treatment, the compli-
ance with external leg compression, and adverse
events associated with the treatment or an eventual
underlying disease. 
RESULTS
Diagnosis of proximal DVT was made with
duplex scanning on 101 occasions (ie, in 65% of the
episodes). Venography was carried out in 15% of
episodes, mostly when a procedure to remove the
clots was contemplated. Of the 84 D-dimer tests
performed, five (6%) had false-negative results. 
Diagnosis of calf vein DVT was advanced in 55
episodes (35%). Its presence was proved with duplex
ultrasound scan in 63% and with venography in 37%.
Of the 44 D-dimer tests performed, 13 (30%) had
false-negative results. 
Treatment was on an outpatient basis in all cases
of calf vein DVT. Of the patients with proximal DVT,
83% underwent outpatient treatment, too. Eleven
patients were admitted to the hospital, nine who had
thrombolysis or thrombectomy and two who were
unfit for home treatment. Overall, 93% of patients
were treated as outpatients, 43% by the referring
physician alone (Table II). Outpatients received dal-
teparin for an average of 5 days (median range, 1-28
days). Either the patients themselves or relatives (in
78% of the cases) injected the dalteparin (Table II).
Compliance with injections was 100%, and no diffi-
culties were reported. All but 14 patients (10%) were
given phenprocoumon. When the patients’ use of
dalteparin stopped, the average prothrombin time
was INR 2.74. The distribution of the INR values is
depicted in Table III. The INR values differed less
than ± 0.5 from the target in 66% and less than ± 1.0
in 85%. Severe deviation (< 1.5; > 5) occurred in
3.8% of measurements.
External leg compression was initiated immedi-
ately in all but two patients (Table II). Compression
was limited to the calf in all cases of crural DVT and
was also judged sufficient for 83% of proximal DVT.
Fixed minimally elastic bandages (Fischer’s dressings)
were applied in 28% of cases because of severe pain
and swelling and left in place day and night for an
average of 4.9 days (range, 2-14 days). The other 72%
of patients were given graduated compression stock-
ings right from the beginning. Sigvaris 503 stockings
(pressure above the ankle, 23-32 mm Hg) were used
in most patients; Sigvaris 504 stockings (pressure
above the ankle, 34-46 mm Hg) were used in 9%. By
the end of the first month, 97% of patients were still
wearing compression hosiery. All were fully mobile
and came to the scheduled visits without exception. 
Follow-up data at 1 month were obtained from
all patients who were treated as outpatients. No evi-
dence of clinical progression or recurrence was
reported. One patient, while fully anticoagulated,
experienced symptoms compatible with pulmonary
embolism but reported them only after they had
vanished. No further workup was done. One patient
had a minor hematoma at the injection site. Another
patient was hospitalized for thyrotoxicosis 6 days
after diagnosis of DVT. 
DISCUSSION
An internal audit of outpatient management of
acute DVT is reported. The survey deals with patients
referred to a downtown center for vascular diseases. All
patients were in an upright position and could walk.
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Table II. Management of 156 consecutive cases of DVT
No. of cases %
Outpatient treatment 145 93
Hospital admission 11 7
Thrombectomy/thrombolysis 9 6
Patients unfit for home treatment 2 1
Responsible for outpatient treatment
Thrombosis center 42 29
Referring physician 63 43
Joint approach 40 28
Provider of the dalteparin injections
Patient 101 70
Relatives 12 8
Practice staff 26 18
Nurse at home 6 4
External leg compression 143 99
Initial bandaging 40 28
Compression stockings from the beginning 103 72
Diagnosis. The diagnosis of proximal DVT with
clinical examination, D-dimer estimation, and
sonography was straightforward. Venography was
performed almost exclusively in candidates undergo-
ing restitutive procedures. 
The diagnosis of calf vein thrombosis was less
easy. There were three reasons for frequent requests
of venography: (1) In about half of the cases a post-
thrombotic syndrome, a complication of varicose
disease, cellulitis, trauma, or recent surgery was pre-
sent in the same leg. These conditions served as an
alternative explanation for the clinical symptoms
and as a risk or triggering factor for the suspected
DVT. Thus, the clinical probability could not be
quantitated. (2) For the same reason ultrasound
scan examinations were often technically difficult
and inconclusive. (3) The test used to measure D-
dimer concentrations had an unexpectedly low sen-
sitivity. Recent work has shown the SimpliRED
assay to have a negative predictive value of only
85.7%.9 Our determination to specifically search for
limited calf DVT may be questioned in the light of
recent work: a D-dimer test (enzyme-linked
immunosorbent assay) with negative results and a
compression sonogram of the popliteal and com-
mon femoral veins with negative results were found
to predict the absence of a major thromboembolic
event in the next 3 months in 97% of patients
referred with suspicion of DVT.10 However,
because earlier studies have shown a substantial rate
of progression of untreated calf DVT11-13 and
because many of our patients were referred specifi-
cally to clear the differential diagnosis of calf pain, it
was important to confirm every reasonable suspi-
cion immediately and objectively.
Treatment. For more than 20 years, we treated
DVT on an outpatient basis according to principle.
We did not select patients specifically, because there
were no study data available specifying which patients
would be at risk if they were not admitted to the hos-
pital. However, we performed some selection anyway
because we undertook a restitutive procedure in 9%
of patients with proximal DVT. These patients all had
acute and extensive DVT and may have presented a
risk for home treatment. Of the remaining 92
patients with proximal DVT, only two were unsuit-
able for outpatient treatment. A proportion of more
than 80% of patients with DVT successfully treated at
home has been reported in other studies as well.3,12
The regimen of outpatient treatment described
meets all standards. The excellence of compliance is
regarded as the result of efforts made to guide the
patients. Because DVT is considered to be a dangerous
disease when left untreated, patients are easily moti-
vated to make the injections and swallow the pills,
measures rightly declared as stopping disease progres-
sion immediately.15 The quality of oral anticoagulation
was in accordance with that reported from recognized
centers.16 However, it seems unsatisfactory to us that
less than two thirds of the prothrombin values are in
the therapeutic range. Self-testing, self-dosing, and
computerized dosing may improve anticoagulant
control to some extent.17,18
External leg compression was used in almost all
patients. Compliance is attributed to its obvious bene-
fits: giving relief from pain and restoring the capability
to walk freely within a short period of time. Our
patients undertake three strolls a day, spending an
average of 2 hours outside of their homes.5 There are
no controlled studies available that would prove the
benefit or necessity of external leg compression in
patients with acute DVT. Furthermore, there is an old
controversy about which kind of compression to apply.
We used, for the sake of simplicity and also in most
patients, hosiery made from natural rubber fibers (elas-
todien, a material of optimal elasticity).19 Measures
were taken on the healthy leg, which resulted in a
strong compression. Nevertheless, discomfort dimin-
ished readily as the edema disappeared with frequent
walking.20 The Unna boot is made of short-stretch
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Table III. Prothrombin time values, obtained at the time of cessation of dalteparin and during the subse-
quent 3 weeks, listed according to the provider of the outpatient treatment 
Prothrombin time INR < 2* INR 2-3* INR > 3*
At the time of cessation of dalteparin 14 67 19
Subsequently, assessed by
Thrombosis center 15 59 26
General practitioner 7 65 28
Joint approach 11 50 39
Total number of prothrombin assays reported was 342.
*Percentage of tests performed under the index condition.
bandages and exerts a moderate compression at rest
but a high pressure during walking because of its poor
elasticity. Therefore, it is well tolerated and can be left
on the leg at night. It is used if the edema is excessive,
indurated, or both; if patients have concurrent neu-
ropathy, angiopathy, or inability to walk; and if patients
are incapable of handling stockings. 
In summary, this survey confirms that if the
described regimen is used, most patients with DVT
who are first seen as outpatients can be treated as
outpatients. There seems to be only one criterion for
patient selection: whether the patient can be moti-
vated to comply with the regimen. Clearly, patients
who might benefit from thrombolysis or thrombec-
tomy should be sent to a center providing such treat-
ment, and (the rare) patients unfit for outpatient
treatment should not be denied hospital admission. 
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DISCUSSION
Dr Hugo Partsch (Vienna, Austria). This remarkable
work from Dr Blättler and his team demonstrates that out-
patient treatment of DVT provided by a well-organized
private practice is effective, safe, and feasible. Patient selec-
tion and care planning are the most important issues to be
discussed, since the eligibility rate of Dr Blättler is the high-
est that you will find in the literature. Of 152 consecutive
patients, only 11 patients, 7%, were admitted to the hospi-
tal, 9 for thrombolysis or thrombectomy and only 2 for
social reasons. Apparently there was no patient who had to
be admitted because of bad general condition, severe con-
comitant disease, or limited cardiopulmonary reserve.
Thirteen patients had chest pain and/or dyspnea suspicious
of pulmonary embolism; however, there was no need for
hospitalization in these cases. Some differences may be
seen comparing the DVT patients who are referred to Dr
Blättler’s office and those who are admitted in our hospital
from outside because of DVT. If we look at our outcome
during the hospital stay of 1289 patients and concentrate
just on the fatal events, which all underwent autopsy in our
institution, 17 patients (ie, 1.3%) died; interestingly, only
three died of pulmonary embolism. Even after 1 month Dr
Blättler did not get note of any fatal event. Dr Blättler saw
malignant disease in 8%. We see it in 18% of 1289 patients.
In more than one third of these patients the malignant dis-
order was newly discovered by our investigations.
Searching for confounding variables that could be taken as
predictors for fatal outcome, we found age over 70,
iliofemoral localization, and the presence of malignant dis-
ease to be statistically significant risk factors. We therefore
think that patients with high age and iliofemoral DVT and
cancer patients are not optimal candidates for home ther-
apy, in addition to the social factors that have been men-
tioned by Dr Blättler and to the individual health condition
of the patient. 
I want to ask you the following questions. First, would
you agree on this proposal? Second, what is your explana-
tion for the fact that your patients are obviously younger
and not so severely ill compared with our patients? The
referral policy into a private institution in a beautiful sub-
urb of Zurich is obviously different from our emergency
admissions into a municipal hospital of Vienna. Third ques-
tion: was there any specific management of the 13 cases
suspicious for having pulmonary emboli concerning diag-
nosis or more intensive surveillance? You have treated these
patients on an outpatient basis. Fourth, do you perform
screening for malignant diseases in selected DVT patients,
and if so, what investigations do you recommend?
I would like to thank my old friend Werner Blättler for
sending me his manuscript and would like to thank the
organizers of this meeting for the privilege of discussing
this outstanding paper. Thank you.
Dr Werner Blättler. Thank you, Hugo, for these ques-
tions. The first concerns the patients we see. It is definitely
so that they are, on the average, 20 years younger than
yours, and we have less malignancy. They may be fitter,
because otherwise, they would be seen in the hospital and
not in our office. But, that is how it is. We do not see bad
cases. The third question was about pulmonary embolism.
We do not treat these patients a different way. One has to
emphasize that the diagnosis is made by investigation. We
ask those patients, and they rarely present with dyspnea,
which is obvious. The last question was about the malig-
nancy. We do not, in our center, check these patients for
an underlying disease. We leave this up to the referring
physician, so we do not have any data on that.
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